Toremifene, a novel antiestrogen, can overcome hsp27-induced drug resistance in human breast cancer cells.

Toremifene, a novel antiestrogen, can overcome hsp27-induced drug resistance in human breast cancer cells. Endocrine. 1996 Jun; 4(3):269-75.

View in: PubMed